Chat GPT och Claude förbjuder Regeringskansliet
Sweden’s Government Offices will block direct access to ChatGPT and Claude on staff computers from October 26, while retaining an internal assistant route for some employees.
Edition · Sun · October 25, 2026
October 25, 2026
4 vertical editions · 16 stories · 41 source citations
Coverage of AI deployment, infrastructure and policy, including a newly documented approach to serving trillion-parameter models.
AI compute is the new oil–and needs a new market
The Economist argues that growing demand for AI computing is exposing limits in how compute capacity is bought and sold.
The same AI request emits 8.5 times more CO2 in Texas than in Sweden
AI infrastructure company Berget AI says the estimated carbon emissions for the same request differ sharply between two data-center locations.
Microsoft develops AI tool that can diagnose ’sequentially’ like a doctor
Microsoft says its MAI-DxO system outperformed physicians on simulated diagnostic cases; prospective clinical evaluation remains ahead.
How we deploy Trillion-parameter frontier models on Cerebras
Cerebras describes mapping the open-source Kimi K3 model across 59 wafer-scale chips, while the company-authored post leaves its performance claims to be independently tested.
This edition covers an interim oncology result, an investigational CAR-T safety disclosure and a proposed U.S. outbound investment rule affecting biotechnology. Single papers and registry-only items were excluded.
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
Amgen reported interim Phase 3 results for tarlatamab with durvalumab as first-line maintenance treatment for extensive-stage small-cell lung cancer.
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Moderna and Merck released Phase 3 results early after data from their personalized mRNA melanoma vaccine study leaked ahead of an ESMO presentation.
Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
Bristol Myers Squibb disclosed a participant death in an early-stage study of an investigational CAR-T therapy for autoimmune disease.
US Treasury proposes a rule to crack down on high-tech investments in China, other adversaries
The proposed Treasury rules would extend outbound-investment controls to biotechnology and other sensitive technology sectors.
Reporting on security and political developments, including a new nationwide round of protests in France.
Ukraine says Starlink connection 'now stable' after network limits
Ukraine said Starlink and Starshield speeds had returned after more than a week of restrictions that disrupted front-line operations.
Tens of thousands of Lula supporters rally on eve of Brazilian election runoff
Luiz Inácio Lula da Silva and Flávio Bolsonaro made final appeals before Brazil’s October 25 presidential runoff.
North Korean leader Kim Jong Un visits China to inaugurate a new cross-border bridge
Kim Jong Un crossed a newly opened bridge into China in a visit framed by both sides as a step toward closer cooperation.
Almost 1,000 arrested as clashes follow another day of mass protests across France
The Interior Ministry estimated 410,000 people joined Saturday demonstrations; unions put turnout at about 800,000, and clashes broke out late in several cities.
Coverage of economic policy and market risks, including the credit exposure created by financing AI infrastructure.
Euro sinks on French debt worries
French bond selling and renewed protests brought fiscal and political risk back into focus for investors.
White House lifts tariffs on some Canadian goods as midterm elections loom
The White House lifted tariffs on some Canadian products, while reporting said other goods could face replacement measures.
Nvidia's role as AI financier faces first big test as neoclouds take market hit
Credit markets are reassessing debt-backed AI infrastructure as Nvidia-backed cloud providers fall and the chipmaker discloses sizeable contingent financing commitments.